What is Acadia Pharmaceuticals's PP&E (net)?

Acadia Pharmaceuticals (ACAD) reported PP&E (net) of $14.65M in Q1 2026.

How has Acadia Pharmaceuticals's PP&E (net) changed year-over-year?

Acadia Pharmaceuticals's PP&E (net) increased by 318.9% year-over-year, from $3.5M to $14.65M.

What is the long-term trend for Acadia Pharmaceuticals's PP&E (net)?

Over 5 years (2020 to 2025), Acadia Pharmaceuticals's PP&E (net) has grown at a -3.9% compound annual growth rate (CAGR), from $9.16M to $7.51M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Acadia Pharmaceuticals ACAD PP&E (Net)

PP&E (Net) at other companies

BiogenBIIB

$3.02B-3.7%

Neurocrine BiosciencesNBIX

$90.9M+4.5%

Catalyst PharmaceuticalCPRX

$994K-19.8%

PTC TherapeuticsPTCT

$52.74M-11.3%

BridgeBio PharmaBBIO

$4.94M-26.2%

Arrowhead ResearchARWR

$374.82M-2.6%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's PP&E (net)?: Acadia Pharmaceuticals (ACAD) reported PP&E (net) of $14.65M in Q1 2026.
How has Acadia Pharmaceuticals's PP&E (net) changed year-over-year?: Acadia Pharmaceuticals's PP&E (net) increased by 318.9% year-over-year, from $3.5M to $14.65M.
What is the long-term trend for Acadia Pharmaceuticals's PP&E (net)?: Over 5 years (2020 to 2025), Acadia Pharmaceuticals's PP&E (net) has grown at a -3.9% compound annual growth rate (CAGR), from $9.16M to $7.51M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.